Myron Holubiak

Myron Z.
Holubiak is the founder of Citius Pharmaceuticals, Inc., founded in 2007, serving as Executive Vice Chairman since 2022.
Mr. Holubiak was the founder of Leonard-Meron Biosciences, Inc., founded in 2013, serving as President, Chief Executive Officer & Director from 2013 to 2016.
Mr. Holubiak is also the founder of Emron, Inc...
Current positions include Chief Executive Officer at NoveCite, Inc., Executive Vice Chairman & Secretary at Citius Oncology, Inc. since 2024, and Director at Children of Chernobyl Relief Foundation.
Former positions include Vice Chairman at 1-800-DOCTORS, Inc. from 2014 to 2017; Chairman at Option Care Health, Inc. from 2012 to 2016; Director at MDRNA, Inc. from 2004 to 2008; Director at Chronimed, Inc. from 2002 to 2004; Director at The Robert Wood Johnson Foundation in 2001; Director at NASTech, Inc.; Independent Director at Intellicell Biosciences, Inc. from 2012 to 2014; Independent Director at Assembly Biosciences, Inc. from 2010 to 2022; Director at bioAffinity Technologies, Inc.; Lead Independent Director at Ventrus Biosciences, Inc. from 2012 to 2022; President & Chief Operating Officer at iPhysicianNet, Inc. from 2001 to 2002; President & Chief Operating Officer at HSC Acquisitions LLC from 2002 to 2007; President at Roche Laboratories, Inc. from 1998 to 2001; Trustee at AMCP Foundation from 2013 to 2015; Trustee at Academy of Managed Care Pharmacy from 2013 to 2015.
Education includes undergraduate degree from the University of Pittsburgh, conferred in 1969.